Women’s Guide to Preventative Health Care

by | May 13, 2022 | Blog, Consulting Group, Genetics, Medical Devices, Pharmaceuticals, Quality, Testing, Treatment, Women, Women's Health

In honor of this week being National Women’s Health Week, it’s important to not only speak about the illnesses and diseases that plague women but also the preventative measures a woman can take to ensure she has a long and happy life.

Preventative care can range from immunizations, testing for sexually transmitted infections (STIs), and more. It should be common sense that staying on top of your personal health is a must-do, but in the age, we currently live in sometimes it falls to the wayside. We women are known for putting aside ourselves for our families, our jobs, or even getting lost in the hustle and bustle of the world. The younger generation of women seems to be more in tune with their bodies and their minds, putting their self-care first.  

What are some ways women can stay a step ahead? Firstly, general health screenings are a good first step. A yearly well-woman visit should be put on every woman’s calendar. This allows your doctor to review and check in on your medical history, assess your risk for certain diseases, get up to date on immunizations or preventative immunizations, and talk openly about healthy lifestyle changes if that’s something you’re lacking in.

During a wellness check-in, it’s also important to make sure your doctor takes the appropriate blood tests to figure out your risk of heart disease. For women, it may not be common knowledge, but heart disease is the leading cause of death in women. Having a regular blood test may not change what illnesses happen to a woman but being proactive can not only save your life but can cut down on larger medical bills in the future.

A final thought for the women readers out there, one preventative measure to take is Ovarian Cancer Screenings. Ovarian cancer has symptoms women would deem as ‘normal’ instead of something to worry about. Fatigue, upset stomach, back pain, or even constipation can be just some of the symptoms. Sounds familiar, doesn’t it? What woman doesn’t feel one, if not all, of the symptoms above at one point or another?

That’s why preventative care is a must-do, instead of a to-do list item that gets pushed down day after day while other things stack up. Take the time, make the appointment, and put yourself first. While EMMA International can’t help set up your preventative care, we can help your company get regulatory approval, and optimize your quality systems, so you have more time for your health! Let EMMA International handle your products’ quality and regulatory compliance so you can make more time for yourself and your health! For more information, give EMMA International a call at 248-987-4497 or email us at info@emmainternational.com.   

Rippey, MD, CAQSM, P. (2021, August). Women’s Guide to Preventative Care [web log]. Retrieved May 7, 2022, from https://familydoctor.org/womens-guide-to-preventive-care/.

Caroline Wiles

Caroline Wiles

Caroline serves as the Marketing and Operations Specialist at EMMA International. She has experience in marketing, sales, operations, human resources, recruitment, and design. She holds a Bachelor of Arts in Business Administration with a concentration in Marketing from Alma College. 

More Resources

FDA’s Refusal to Accept Process

FDA’s Refusal to Accept Process

Before the submission of a 510(k) premarket notification, the purpose of which is to notify the FDA of the manufacturer’s intent to market a medical device,[i] there is a provision for acceptance review. This review serves as a method to assess whether a submission is administratively complete and includes all necessary information for FDA to determine substantial equivalence under section 513(i) of the Federal Food, Drug, and Cosmetic (FD&C) Act (21 United States Code (U.S.C.) § 360c(i)). To establish substantial equivalence under this provision, FDA must find the same intended use as the predicate device and either have the same technological characteristics as the predicate device or appropriate clinical and scientific data necessary to establish that the device is safe and effective as the predicate device. If the Authority is unable to determine substantial equivalence due to insufficient information, it may request for additional information to make that determination. Therefore, as a part of the acceptance review, the FDA staff follows the acceptance checklist[ii] to ensure that the application is administratively complete. These administrative elements are identified as RTA items and are required to be presented. The purpose of conducting the acceptance review is for the Lead Reviewer to determine whether the 510(k) submission meets the minimum threshold of acceptability and should be accepted for substantive review.[iii]
Empowering Your Workforce through Kaizen

Empowering Your Workforce through Kaizen

Last week, I touched on the idea of involving and empowering all employees in the workplace through the corrective and preventive actions process by fostering taking initiative and a problem-solving (refer to blogpost ‘The Art of Addressing Non-Conformances in Operations’). To expand on this concept a bit further, we’re going to be looking at Kaizen–a continuous improvement strategy in which employees at all levels are also empowered to solve problems towards big gains.
FDA’s draft guidelines on Remote Regulatory Assessments (RRAs)

FDA’s draft guidelines on Remote Regulatory Assessments (RRAs)

The pandemic has been a challenging time for all industries including the Food and Drug Administration (FDA). The FDA had to alter the manner in which it conducted its operations. One set of tools adopted by the FDA in response to COVID-19 was the remote regulatory assessment (RRAs).

Ready to learn more about working with us?

Pin It on Pinterest

Share This